PolyPid Ltd — Stato Patrimoniale (NASDAQ:PYPD) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Totale attivo 75.85 M44.23 M25.97 M15.37 M25.22 M22.31 M Totale passività 2.88 M8.08 M19.86 M17.47 M17.54 M11.33 M Patrimonio netto totale 72.78 M35.96 M5.83 M-2.1 M7.68 M10.97 M Totale passività e patrimonio netto 75.85 M44.23 M25.97 M15.37 M25.22 M22.31 M Debito totale ——4.26 M2.44 M7.42 M988 K Indebitamento netto ——-8.33 M-2.87 M-12.81 M-4.59 M

Notizie

PolyPid presenterà dati farmacocinetici di D-PLEX100 all’ESCMID Global

PolyPid receives $4.3M FDA fee waiver for D-PLEX100 application

PolyPid al Citizens Life Sciences: Mosse Strategiche ed Espansione

PolyPid at Citizens Life Sciences: Strategic Moves and Market Expansion

McDonald’s, Cisco, Shopify, and more set to report earnings Wednesday

PolyPid Ltd. (PYPD) Discusses the Science and Business Case for D-PLEX100 in Tackling Surgical Site Infections Transcript

Le azioni PolyPid salgono dopo il supporto della FDA per la NDA di D-PLEX100

PolyPid stock rises after FDA supports NDA submission for D-PLEX100

PolyPid riceve supporto FDA per la presentazione NDA di D-PLEX100

PolyPid receives FDA support for D-PLEX100 NDA submission

Rating del titolo PolyPid confermato a Market Outperform da Citizens

PolyPid stock rating reiterated at Market Outperform by Citizens